← Eichor
Study identifier: NCT06501079 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Dexamethasone Versus Mg Added to Bupivacaine Used in ESPB for Perioperative Pain Control in Patients Undergoing Unilateral Nephrectomy

Condition: Renal Neoplasm  ·  Sponsor: National Cancer Institute, Egypt

PhaseNA
Planned participants78
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

Aim of the study: The current study aims to compare the effect of adding dexamethasone versus magnesium sulfate to bupivacaine in ultrasound-guided erector spinae plane block on the severity of postoperative pain. Primary Objectives: \- To compare the effect of ESPB without additives to the effect of adding dexamethasone and to the impact of adding magnesium sulfate in the form of post-operative morphine consumption

This description comes directly from the study's public registry record.

Talk to the study team

Ahmed M Soliman  ·  01286979695  ·  ams21787arif@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

National Cancer institute - Cairo UniversityCairo, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06501079